Generalized Periodontitis

• CLINICAL_TRIALS trial_result · 2024-02-09
  Clinical Trial Update: Contribution of an Antiviral Drug (Valaciclovir) in the Treatment of Generalized Periodontitis (Stage III or IV and Grade A, B or C): Prospective, Randomized and Double Blind Clinical Trial [Phase 3]

  A Phase 3 randomized, double-blind trial evaluating the contribution of valaciclovir in treating generalized chronic periodontitis.

• CLINICAL_TRIALS trial_result · 2020-08-13
  Clinical Trial Update: Moxifloxacin in Situ Gel to Treat Periodontal Pocket. [Phase 4]

  Phase 4 clinical trial assessing moxifloxacin in situ gel for treating chronic generalized periodontitis has completed.

• CLINICAL_TRIALS trial_result · 2018-05-23
  Clinical Trial Update: Effect of Ashwagandha on Salivary Antioxidant and Serum c Reactive Protein in Chronic Generalized Periodontitis [Phase 1, Phase 2]

  This clinical trial evaluated the effects of Ashwagandha on salivary antioxidant levels and serum C-reactive protein in chronic periodontiti…

• CLINICAL_TRIALS trial_result · 2014-05-29
  Clinical Trial Update: EFFECT OF SELECTIVE COX-2 INHIBITOR (ETORICOXIB) ALONG WITH SCALING AND ROOT PLANING (SRP) ON CLINICAL PARAMETERS AND SALIVARY LEVEL OF SUPEROXIDE DISMUTASE IN CHRONIC GENERALIZED PERIODONTITIS A DOUBLE-BLIND, PLACEBO-CONTROLLED, DOUBLE-MASKED RANDOMIZED CONTROLLED TRIAL (RCT). [Phase 4]

  Phase 4 randomized trial evaluating the effect of etoricoxib, a selective COX-2 inhibitor, as an adjunct to scaling and root planing on clin…